News

Best Life on MSN20h
Ozempic and Wegovy May Have Landed 25,000 People in the ER—Here's the Scary Reason Why
Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.
Weight-Loss Drugs Have Sent a Shocking Number of People to the Emergency Room, New Study Claims
A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...
Healio2d
Semaglutide tied to significant improvements in MASH, liver fibrosis at 72 weeks
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...
Imitation weight-loss drugs boosted Hims & Hers. Executives cashed in.
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
Semaglutide Shows Major Promise for Treating Serious Liver Disease
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
Applied Clinical Trials Online1d
Semaglutide Significantly Improves Steatohepatitis, Fibrosis in Phase III MASH Trial
Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...
Fierce Pharma1d
Madrigal's Rezdiffra, the first-ever MASH drug, beats sales projections for 4 quarters in a row
Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...
News-Medical.Net3d
Semaglutide shows promise in treating severe liver disease
Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE ...
Ozempic is growing in popularity — it’s also sending people to the ER
An analysis of emergency visits related to the active ingredient in drugs like Ozempic and Wegovy have exposed a surprising ...